Related Articles
Elevated CD133, but not VEGF or EGFR, as a predictive marker of distant recurrence after preoperative chemoradiotherapy in rectal cancer
Clinical significance of radiation-induced CD133 expression in residual rectal cancer cells after chemoradiotherapy
Predictive value of Smac, VEGF and Ki-67 in rectal cancer treated with neoadjuvant therapy
Cancer stem cell-related factors are associated with the efficacy of pre-operative chemoradiotherapy for locally advanced rectal cancer
Leucine‑rich repeat‑containing G protein‑coupled receptor 5 and CD133 expression is associated with tumor progression and resistance to preoperative chemoradiotherapy in low rectal cancer